Search results
All genres
Journal Article (27)
2023
Journal Article
24 (11), 9260 (2023)
Reversal of Tau-dependent cognitive decay by blocking adenosine A1 receptors: Comparison of transgenic mouse models with different levels of tauopathy. International Journal of Molecular Sciences 2019
Journal Article
1184, pp. 97 - 103 (2019)
Presynaptic Pathophysiology Encoded in Different Domains of Tau - Hyper-Versus Hypoexcitability? Advances in Experimental Medicine and Biology
Journal Article
14, 13 (2019)
Functional networks are impaired by elevated tau-protein but reversible in a regulatable Alzheimer's disease mouse model. Molecular Neurodegeneration
Journal Article
56 (5), pp. 3751 - 3767 (2019)
Suppressing Tau aggregation and toxicity by an anti-aggregant Tau fragment. Molecular Neurobiology 2018
Journal Article
117, pp. 189 - 202 (2018)
Glutamatergic nervous system degeneration in a C. elegans TauA152T tauopathy model involves pathways of excitotoxicity and Ca2+ dysregulation. Neurobiology of Disease
Journal Article
18 (5), pp. 3271 - 3281 (2018)
Reversible cation-selective attachment and self-assembly of human Tau on supported brain lipid membranes. Nano Letters 2017
Journal Article
12, 88 (2017)
Anti-aggregant tau mutant promotes neurogenesis. Molecular Neurodegeneration
Journal Article
57, pp. 47 - 63 (2017)
Time course of Tau toxicity and pharmacologic prevention in a cell model of Tauopathy. Neurobiology of Aging
Journal Article
5, 91 (2017)
Atypical, non-standard functions of the microtubule associated Tau protein. Acta Neuropathologica Communications
Journal Article
292 (29), pp. 12192 - 12207 (2017)
Axodendritic sorting and pathological missorting of Tau are isoform-specific and determined by axon initial segment architecture. The Journal of Biological Chemistry
Journal Article
1523, pp. 335 - 340 (2017)
Tracking Tau in neurons: How to transfect and track exogenous tau into primary neurons. Methods in Molecular Biology
Journal Article
1523, pp. 327 - 334 (2017)
Tracking Tau in neurons: How to grow, fix, and stain primary neurons for the investigation of Tau in all developmental stages. Methods in Molecular Biology 2016
Journal Article
17 (4), pp. 552 - 569 (2016)
The Tau/A152T mutation, a risk factor for frontotemporal-spectrum disorders, leads to NR2B receptor-mediated excitotoxicity. EMBO Reports
Journal Article
113 (41), pp. 11597 - 11602 (2016)
Adenosine A1 receptor antagonist rolofylline alleviates axonopathy caused by human Tau δK280. Proceedings of the National Academy of Sciences of the United States of America
Journal Article
36, 1592, pp. 52 - 58 (2016)
Tau neurotoxicity and rescue in animal models of human Tauopathies. Current Opinion in Neurobiology
Journal Article
11 (1), 96 (2016)
Tau mutant A152T, a risk factor for FTD/PSP, induces neuronal dysfunction and reduced lifespan independently of aggregation in a C. elegans Tauopathy model. Molecular Neurodegeneration
Journal Article
4, 17 (2016)
Age-dependent neuroinflammation and cognitive decline in a novel Ala152Thr-Tau transgenic mouse model of PSP and AD. Acta Neuropathologica Communications 2015
Journal Article
12 (9), pp. 814 - 828 (2015)
Identification of small molecule inhibitors of tau aggregation by targeting monomeric tau as a potential therapeutic approach for tauopathies. Current Alzheimer Research
Journal Article
44 (3), pp. 937 - 947 (2015)
Carboxy terminus heat shock protein 70 interacting protein reduces tau-associated degenerative changes. Journal of Alzheimer's Disease
Journal Article
6, 7025 (2015)
A mechanistic model of tau amyloid aggregation based on direct observation of oligomers. Nature Communications